title: PAK1 limits the expression of the pro-apoptotic protein Bad in pancreatic islet β-cells.
abstract: Human type 2 diabetes is associated with β-cell apoptosis, and human islets from diabetic donors are ∼80% deficient in PAK1 protein. Toward addressing linkage of PAK1 to β-cell survival, PAK1-siRNA targeted MIN6 pancreatic β-cells were found to exhibit increased caspase-3 cleavage, cytosolic cytochrome-C and the pro-apoptotic protein Bad. PAK1(+/-) heterozygous mouse islets recapitulated the upregulation of Bad protein expression, as did hyperglycemic treatment of human or mouse islets; Bad levels were exacerbated most in PAK1(+/-) islets subjected to hyperglycemic stress. These data implicate PAK1 in β-cell survival via quenching of Bad protein expression, and suggest PAK1 as potential molecular target to preserve β-cell mass.
authors: Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
authors: Zhanxiang
authors: Z
authors: Wang
authors: Debbie C
authors: DC
authors: Thurmond
keywords: Apoptosis; Bad; Human islet; Mouse islet; PAK1; Pancreatic β-cell
references: J Mol Cell Cardiol. 2010 Feb;48(2):406-14
references: 19852968
references: J Biol Chem. 2010 Feb 26;285(9):6186-97
references: 20028975
references: Diabetes. 2010 Mar;59(3):644-52
references: 19959756
references: Diabetes. 2001 Jun;50(6):1290-301
references: 11375329
references: Diabetes. 2004 Feb;53 Suppl 1:S119-24
references: 14749276
references: Nature. 2001 Dec 13;414(6865):792-8
references: 11742411
references: Diabetologia. 2012 May;55(5):1346-54
references: 22286529
references: Mol Cancer Ther. 2012 Jan;11(1):45-56
references: 22057915
references: J Biol Chem. 2007 Mar 30;282(13):9536-9546
references: 17289663
references: Eur J Endocrinol. 2003 Aug;149(2):99-102
references: 12887285
references: PLoS One. 2011;6(11):e27637
references: 22096607
references: Blood. 2009 Mar 19;113(12):2695-705
references: 19124833
references: Adv Exp Med Biol. 2010;654:515-35
references: 20217513
references: Am J Physiol Endocrinol Metab. 2010 Apr;298(4):E735-41
references: 20028968
references: Diabetes. 2003 Jan;52(1):102-10
references: 12502499
references: Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1487-95
references: 21705677
references: Mol Cell Biol. 2000 Jan;20(2):453-61
references: 10611223
references: Biochem Biophys Res Commun. 2008 Jun 13;370(4):552-6
references: 18402774
references: Curr Med Chem. 2009;16(31):4058-65
references: 19754424
references: J Neurosci Res. 2005 Mar 15;79(6):809-15
references: 15693023
references: J Biol Chem. 2011 Dec 2;286(48):41359-41367
references: 21969371
references: Diabetes. 2003 Mar;52(3):581-7
references: 12606496